Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd.

This study is testing whether a combination of two immunotherapy drugs, IBI310 and sintilimab, can help people with advanced liver cancer that cannot be removed by surgery. It will involve about 680 adults who have not yet received any drug treatment for their cancer. The main go…